Role Of Lipid Concentrations and Apolipoproteins In Altering ApoB Metabolism and Promoting Coronary Events
Reference63 articles.
1. LaRosa JC, Hunninghake D, Bush D, Criqui MH, Getz GS, Gotto AM Jr, Grundy SM, Rakita L, Robertson RM, Weisfeldt ML, Cleeman JI. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung and Blood Institute. Circulation 1990; 81: 1721–1733. 2. Carleton RA, Dwyer J, Finberg L, Flora J, Goodman DS, Grundy SM, Havas S, Hunter GT, Kritchevsky D, Lauer RM, Leupker RV, Ramirez AG, Van Horn L, Stason WB, Stokes J. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction, A statement from the National Cholesterol Education Program. Circulation 1991; 83: 2154–2232. 3. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 1995; 76: 69C–77C. 4. Rose G, Hamilton PJ, Keen H, Reid DD, McCartney P, Jarrett RJ. Myocardial ischemia, risk factors and death from coronary heart disease Lancet 1997; 1: 105–109. 5. Martin JM, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361, 662 men. Lancet 1986; 2: 933–936.
|
|